ACCENTIA BIOPHARMACEUTICALS
DEAD

Serial Number

78498858

Owner

Accentia Biopharmaceuticals, Inc.

Attorney

Corey K. Cho

Filing Date

Oct 13, 2004

Add to watchlist:

No watchlists yet
View on USPTO

ACCENTIA BIOPHARMACEUTICALS Trademark

Serial Number: 78498858

ACCENTIA BIOPHARMACEUTICALS is a trademark filed by Accentia Biopharmaceuticals, Inc. on October 13, 2004. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Accentia Biopharmaceuticals, Inc. (18 trademarks)

Suite 101
Tampa, FL 33609

Entity Type: 03

Accentia, Inc. (5 trademarks)

5310 Cypress Center Drive #101
Tampa, FL 33609

Entity Type: 03

Trademark Details

Filing Date

October 13, 2004

Registration Date

Not Registered

Published for Opposition

February 13, 2007

Goods & Services

Scientific devices for the development, production and proliferation of cells and proteins not for use with diabetes associated conditions, namely bioreactors for automated cell culture and protein production; automated protein purification systems comprising filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; cultureware and replacement parts for bioreactors and purification systems including filtration cassettes, filtration membranes, filtration modules, columns, chromatography columns, resin packed columns, ion exchange columns, purification monitors, ultraviolet monitors, photometers, gas exchange cartridges, cell culture cartridges, incubation chambers, pumps, culture chambers, valves, tubing, reservoirs, liquid reservoirs, cell culture media reservoirs and collection vessels; and control systems for use with bioreactors and purification systems namely microprocessors, process control computers, culture monitors, purification monitors, electronic data recorders, ultraviolet monitors and photometers

Biologic product preparations, namely proteins, antibodies, vaccine compositions, antifungals, antitussives, decongestants, cell based products, namely coagulation factors and immune stimulants, and growth factors, namely cytokines, hormones, morphogens and interleukins for use in the diagnosis, cure, mitigation, treatment and prevention of diseases and conditions not associated with diabetes, namely sinus infections, asthma, sinus inflammation, chronic rhinosinusitis, allergic fungal rhinosinusitis, cancers, lymphomas, Non-Hodgkins lymphoma, B-cell Non-Hodgkins lymphoma, diseases of the immune system, tissue repair and tissue growth applications, allergies, cough, cold, inflammation, fever, nausea and vomiting; and pharmaceutical preparations for the treatment and mitigation of pain

Business consultation in the field of commercialization of pharmaceuticals not for use with diabetes associated conditions; distributorship in the field of pharmaceutical products not for use with diabetes associated conditions

Drug delivery systems for diseases and conditions not associated with diabetes

Pharmaceutical drug development services not associated with diabetes

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 8, 2009 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2009 ABN6
REVIEW OF CORRESPONDENCE COMPLETE
Dec 11, 2008 CORV
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 11, 2008 AITU
PAPER RECEIVED
Dec 2, 2008 MAIL
SOU EXTENSION 3 GRANTED
Nov 5, 2008 EX3G
SOU EXTENSION 3 FILED
Nov 5, 2008 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 5, 2008 EEXT
SOU EXTENSION 2 GRANTED
May 6, 2008 EX2G
SOU EXTENSION 2 FILED
May 6, 2008 EXT2
SOU TEAS EXTENSION RECEIVED
May 6, 2008 EEXT
SOU EXTENSION 1 GRANTED
Nov 7, 2007 EX1G
SOU EXTENSION 1 FILED
Nov 7, 2007 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 7, 2007 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 23, 2007 ASCK
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 8, 2007 NOAM
PUBLISHED FOR OPPOSITION
Feb 13, 2007 PUBO
NOTICE OF PUBLICATION
Jan 24, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 21, 2006 PREV
ASSIGNED TO LIE
Dec 21, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2006 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 6, 2006 XAEC
EXAMINERS AMENDMENT E-MAILED
Dec 6, 2006 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 6, 2006 CNEA
CONTINUATION OF FINAL REFUSAL E-MAILED
Jun 21, 2006 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Jun 21, 2006 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2006 TROA
FINAL REFUSAL E-MAILED
Dec 14, 2005 GNFR
FINAL REFUSAL WRITTEN
Dec 14, 2005 CNFR
AMENDMENT FROM APPLICANT ENTERED
Dec 11, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2005 CRFA
PAPER RECEIVED
Nov 22, 2005 MAIL
NON-FINAL ACTION E-MAILED
May 17, 2005 GNRT
NON-FINAL ACTION WRITTEN
May 17, 2005 CNRT
NON-FINAL ACTION E-MAILED
May 16, 2005 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2005 CNRT
ASSIGNED TO EXAMINER
May 16, 2005 DOCK
NEW APPLICATION ENTERED
Oct 20, 2004 NWAP